Literature DB >> 9237249

The expression of transforming growth factor-beta s and TGF-beta receptor mRNA and protein and the effect of TGF-beta s on human myometrial smooth muscle cells in vitro.

X M Tang1, Q Dou, Y Zhao, F McLean, J Davis, N Chegini.   

Abstract

In this study we investigated the expression of transforming growth factor-beta (TGF-beta) isoform and TGF-beta receptor mRNA and protein, and the effect of TGF-beta 1-3 on the rate of DNA synthesis and proliferation of human myometrial smooth muscle cells in vitro. To determine these, we utilized primary cultures of myometrial smooth muscle cells, standard and competitive quantitative reverse transcription-polymerase chain reaction (RT-PCR), immunocytochemistry, enzyme-linked immunoassay, radioreceptor assay, [3H] thymidine incorporation and cell proliferation assay. Standard RT-PCR and immunocytochemistry revealed that myometrial smooth muscle cells express TGF beta 1-3 and TGF-beta type I-III receptor (TGF-beta R) mRNA and protein. Quantitative RT-PCR, using an external synthetic RNA standard, indicated that the cells express 10 copies/cell of TGF-beta 1 and TGF-beta 2, less than one copy/cell of TGF-beta 3 and TGF-beta type IR, three copies/cell of type IIIR, and > 200 copies/cell, of TGF-beta type IIR mRNA. The cells also synthesized and released TGF-beta 1 at the rate of 7.8 +/- 0.7 ng/10(6) cells, of which 1.4 +/- 0.2 ng/10(6) cells was in an active form. The rate of [3H] thymidine incorporation or proliferation of subconfluent quiescent smooth muscle cells was not altered by TGF-beta s (0.1-10 ng/ml) under serum-free conditions, nor in the presence of 10% fetal bovine serum (FBS). TGF-beta 1-3 at 0.25-0.5 ng/ml in the presence of 2% FBS, which induces half maximal stimulation of these cells, stimulated the rate (P < 0.05), whereas at higher doses it reduced the rate of [3H]-thymidine incorporation compared to the controls. The effect of TGF-beta was partially reversible using neutralizing antibodies specific to TGF-beta 1, TGF-beta 2 (10 micrograms/ml) or TGF-beta 3 (3-6 micrograms/ml). TGF-beta s had no significant effect on cell proliferation determined by cell counting. The data indicate that human myometrial smooth muscle cells express the necessary components of the TGF-beta system, suggesting an autocrine/paracrine role for TGF-beta s in myometrium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237249     DOI: 10.1093/molehr/3.3.233

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  25 in total

1.  1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells.

Authors:  Sunil K Halder; J Shawn Goodwin; Ayman Al-Hendy
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

2.  1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells.

Authors:  Sunil K Halder; Kevin G Osteen; Ayman Al-Hendy
Journal:  Biol Reprod       Date:  2013-12-26       Impact factor: 4.285

3.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

Review 4.  The TGF-β Family in the Reproductive Tract.

Authors:  Diana Monsivais; Martin M Matzuk; Stephanie A Pangas
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-10-03       Impact factor: 10.005

Review 5.  The role of progesterone signaling in the pathogenesis of uterine leiomyoma.

Authors:  J Julie Kim; Elizabeth C Sefton
Journal:  Mol Cell Endocrinol       Date:  2011-06-06       Impact factor: 4.102

6.  Can vitamin D reduce the risk of uterine fibroids?

Authors:  Ayman Al-Hendy; Marwa Badr
Journal:  Womens Health (Lond)       Date:  2014-07

7.  TGFBR1 is required for mouse myometrial development.

Authors:  Yang Gao; Kayla J Bayless; Qinglei Li
Journal:  Mol Endocrinol       Date:  2014-02-07

8.  Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function.

Authors:  Md Soriful Islam; William H Catherino; Olga Protic; Milijana Janjusevic; Peter Clarke Gray; Stefano Raffaele Giannubilo; Andrea Ciavattini; Pasquale Lamanna; Andrea Luigi Tranquilli; Felice Petraglia; Mario Castellucci; Pasquapina Ciarmela
Journal:  J Clin Endocrinol Metab       Date:  2014-02-25       Impact factor: 5.958

9.  Early growth response-2 expression in uterine leiomyoma cells: regulation and function.

Authors:  Ping Yin; Antonia Navarro; Feng Fang; Anna Xie; John S Coon; Carrie Richardson; Serdar E Bulun
Journal:  Fertil Steril       Date:  2011-06-24       Impact factor: 7.329

10.  Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.

Authors:  John M Norian; Minnie Malik; Candace Y Parker; Doina Joseph; Phyllis C Leppert; James H Segars; William H Catherino
Journal:  Reprod Sci       Date:  2009-08-21       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.